JUAN JOSÉ
LAHUERTA PALACIOS

Forscher bis um 2020

Foto de JUAN JOSÉ

Foto de Hospital Universitari de Tarragona Joan XXIII

Hospital Universitari de Tarragona Joan XXIII

Tarragona, España

Publikationen in Zusammenarbeit mit Forschern von Hospital Universitari de Tarragona Joan XXIII (3)

2015

Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: Results of a prospective phase 2 Spanish/PETHEMA trial
Haematologica, Vol. 100, Núm. 8, pp. 1096-1102

2010

Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study
Haematologica, Vol. 95, Núm. 11, pp. 1913-1920

2007

Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis
Leukemia, Vol. 21, Núm. 1, pp. 143-150